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we are now ourselves developing an In-house software to do 
this. The RANDO Man Phantom (The Phantom Laboratories, 
Salem, New York) was used as a model. RANDO represents a 
175cm tall and 73.5kg male figure. The phantom is 
constructed with a natural human skeleton which is cast 
inside soft tissue-simulating material. An image fusion was 
carried out between a RANDO OSS and a RANDO CT scan. A 
Body structure was created in our CT scan. In order to fusion 
it with the 3D-OSS we used MeshLab (a free processing 
system for 3D triangular meshes). 
 
Results: Image fusion was successfully performed and the 
accuracy of it was measured both using predefined 
corresponding landmarks in the CT and visual confirmation. 
We performed this process for two locations on the phantom, 
Head & Neck and Body, and in both cases we got an accurate 
agreement. 
 
 
 
Conclusion: This study was carried out using an existing 
commercial app in order to prove the feasibility of the 
method, using only a smartphone and free software. 
Therefore, we think it reasonable to believe that making your 
own 3D-OSS system could be done both in a simple and in a 
much cheaper way than the usually commercial alternatives 
available on the market. 
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Purpose or Objective: In external beam radiotherapy for 
prostate cancer, image-guidance using fiducial-markers 
decrease set-up error and inter-fractional organ-motion 
error. However, daily deformity and/or rotation of the 
prostate/seminal vesicle could not be adequately detected 
by the verification of fiducial-marker position alone. The 
purpose of this study was to know how many margins should 
be added to compensate for the daily deformity and/or 
rotation of the prostate/seminal vesicle in the image-guided 
radiotherapy using fiducial-markers. 
 
Material and Methods: Three-hundred ten fractions of nine 
patients with prostate cancer were examined. Patient setup 
was performed according to the position of two intra-
prostate fiducial-markers (first-stage). Thereafter, with 
considering deformity and/or rotation of the 
prostate/seminal vesicle, the patient position was moved to 
the best position to achieve an alignment of contours of the 
prostate/seminal vesicle on daily cone-beam CT and contours 
of the clinical target volumes delineated on treatment 
planning CT (second-stage). Distance of movement in the 
second-stage was measured. 
 
Results: An alignment in the second-stage was needed in 47 
fractions of 310 fractions (15.2%). In 43 fractions (13.9%), 
movement of 1 mm was needed only in antero-posterior (AP) 
direction. Movement of 2 mm in AP direction, movement of 1 
mm in cranio-caudal (CC) direction, and movement of 1 mm 
in AP and CC directions were needed in two fractions (0.6%), 
in one fraction (0.3%), and in one fraction (0.3%), 
respectively. No fraction needed an alignment in left-right 
direction. 
 
Conclusion: With regard to image-guided external beam 
radiotherapy based on intra-prostate fiducial-marker 
position, margins of 1-2 mm in AP direction are necessary to 
compensate for the daily deformity and/or rotation of the 
prostate/seminal vesicle. 
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Purpose or Objective: Linac radiation isocenter describes a 
path while gantry and couch are rotating during the 
treatment delivery of typical non-coplanar SRS plans. The 
aim of this study is to investigate the dosimetric impact of 
this isocenter "wobble" in SRS of a vestibular schwannoma 
(VS), and to validate the PTV margin used in our clinical 
practice. 
 
Material and Methods: Five VS cases were enrolled in this 
study. The PTV was generated in the Eclipse TPS by 
expanding the CTV by an isotropic 2 mm margin, according to 
our SRS policy. A SRS non-coplanar plan ("reference plan") 
was designed in the Eclipse TPS by using static gantry IMRT 
technique. Eleven beams (6 MV) from a Varian Clinac 
equipped with a 120 Millennium MLC were used. Dose of 12.5 
Gy (100%) was prescribed to cover 99 % of PTV.  
On the other hand, fifteen CBCT-guided end-to-end (E2E) 
tests using a skull phantom were performed. E2E test permits 
to quantify the radiation isocenter misalignments in the X 
(lateral), Y (anterior-posterior) and Z (superior-inferior) 
directions.  
For each VS case, eight X-Y-Z shifts generated from "mean ± 
1.96 x SD" misalignments reported by E2E tests were 
simulated in the Eclipse TPS, resulting in eight "shifted 
plans". The following metrics were computed for each shifted 
plan and compared to the reference plan values: i) dose 
coverage of the CTV (D99%_CTV), ii) maximum dose to 
brainstem, iii) mean doses to cochlea, and iv) V10Gy, V5Gy 
and V2.5Gy of the brain (including the PTV). 
 
Results: 1) Isocenter misalignments revealed by E2E tests 
were (mean ± SD): -0.4 ± 0.7 mm, -0.2 ± 0.5 mm and 0.2 ± 
0.4 mm, in the X, Y and Z directions, respectively. Gaussian 
behavior was observed for each direction (p> 0.05; Shapiro-
Wilk test). The probability of having shifts ≥ 2 mm is less than 
1% in Lat, AP, and SI directions.  
2) Target coverage was assured in the shifted plans; 
D99%_CTV: 103.1% ± 5.8% .  
3) Shifted plans vs. reference ones revealed not statistically 
differences (p> 0.05; Two-tailed Student t-test) in brainstem 
maximum dose (7.1 ± 3.0 Gy vs. 7.2 ± 3.1 Gy) ; cochlear 
mean dose (5.3 ± 4.1 Gy vs. 5.1 ± 4.4 Gy) ; V10Gy brain (2.3 ± 
1.5 cm3 vs. 2.3 ± 1.6 cm3); V5Gy brain (8.6 ± 5.1 cm3 vs. 8.6 
± 5.8 cm3); and V2.5Gy brain (43.4 ± 26.7 cm3 vs. 43.5 ± 30.1 
cm3). 
 
Conclusion: 
1) The radiation isocenter "wobble" did not increase 
significantly the doses to brainstem, cochlea and brain.  
2) Our study demonstrated that the 2 mm PTV margin used in 
our clinical practice was adequate for SRS treatment of VS.  
 
 
